Question 1

What does Bioverativ do?

Accepted Answer

Bioverativ is a global biotechnology company dedicated to transforming the lives of people living with hemophilia and other blood disorders.

Question 2

In what sectors does Bioverativ operate?

Accepted Answer

Bioverativ operates in Biotechnology.

Question 3

How many companies has Bioverativ acquired?

Accepted Answer

Bioverativ has made 1 acquisitions between 2017-2017, with a total disclosed deal value of $400.0M.

Question 4

What companies are owned by Bioverativ?

Accepted Answer

Companies acquired by Bioverativ include True North Therapeutics.

Question 5

What are Bioverativ's major acquisitions?

Accepted Answer

Bioverativ's largest acquisitions include True North Therapeutics ($400.0M, 2017).

Question 6

What is Bioverativ's largest acquisition?

Accepted Answer

Bioverativ's largest disclosed acquisition is True North Therapeutics for $400.0M (2017).

Question 7

What was Bioverativ's first acquisition?

Accepted Answer

Bioverativ's first recorded acquisition was True North Therapeutics in 2017 for $400.0M.

Question 8

What was Bioverativ's most recent acquisition?

Accepted Answer

Bioverativ's most recent acquisition is True North Therapeutics, announced May 2017 for $400.0M.

Question 9

What is the average deal size for Bioverativ acquisitions?

Accepted Answer

The average disclosed deal size for Bioverativ acquisitions is $400.0M.

Question 10

What is the median deal size for Bioverativ acquisitions?

Accepted Answer

The median disclosed deal size for Bioverativ acquisitions is $400.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Bioverativ spent on acquisitions?

Accepted Answer

Bioverativ has spent at least $400.0M across its disclosed acquisitions (of 1 total deals; some prices are undisclosed).

Question 12

Which sector has Bioverativ spent the most on?

Accepted Answer

Bioverativ has committed the most disclosed capital to Biotechnology companies — about $400.0M across its deals in that sector.

Question 13

What sectors does Bioverativ usually acquire in?

Accepted Answer

Bioverativ most frequently acquires companies in Biotechnology, Clinical Trials, Health Care.

Question 14

In which sector has Bioverativ made the most acquisitions?

Accepted Answer

Bioverativ has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did Bioverativ make the most acquisitions?

Accepted Answer

Bioverativ made the most acquisitions in 2017, with 1 deal.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Bioverativ

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by Bioverativ

Explore 200,000+ acquisitions — free

Recent News related to Bioverativ

FAQs about Bioverativ

People who checked this page also checked these